FCAR and neoplasm: Neutrophil-dependent ability induced by different tumor-associated antigens to kill tumor cells had been confirmed in extensive preclinical experiments in CD89 transgenic mice (including breast, colon, renal cell carcinoma, and T- and B-cell lymphoma) (313).